Market Share of Human Insulin Drugs And Delivery Devices Industry
The market is highly consolidated, with three major manufacturers holding a global market presence and the remaining manufacturers confined to other local or region-specific manufacturers. Mergers and acquisitions that happened between the players in the recent past have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance to develop and commercialize Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Human Insulin Drug and Delivery Device Market Leaders
-
Novo Nordisk
-
Sanofi
-
El lilly
-
Medtronics
-
Roche
*Disclaimer: Major Players sorted in no particular order
